Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annette Gudmann Hansen

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Scandinavian Journal of Immunology|August 29, 2025
Treat-To-Target: Emergence of Second-Generation CD40L Inhibitors for Treatment of SLE-Identifying Beneficial Patient Candidates for CD40L Inhibitors in a Cross-Sectional SLE CohortKathrine Pedersen, Annette Gudmann Hansen, Yaseelan Palarasah, et al.
Journal of Immunological Methods|June 13, 2024
Development of an immunoassay for quantification of soluble human CD40L (CD154) in plasma and serum samplesKathrine Pedersen, Nick Stub Laursen, Annette Gudmann Hansen, et al.
Frontiers in Immunology|August 8, 2022
Structure-Guided Engineering of a Complement Component C3-Binding Nanobody Improves Specificity and Adds Cofactor ActivityHenrik Pedersen, Rasmus Kjeldsen Jensen, Annette Gudmann Hansen, et al.
Clinical and Experimental Immunology|July 5, 2023
Differentiating between activation via the lectin or the classical complement pathway in patients with systemic lupus erythematosusMads Lamm Larsen, Anne Troldborg, Erik J M Toonen, et al.
Frontiers in Immunology|May 21, 2020
Complement Receptor 2 Based Immunoassay Measuring Activation of the Complement System at C3-Level in Plasma Samples From Mice and HumansLene Halkjær, Anne Troldborg, Henrik Pedersen, et al.
Journal of Clinical and Translational Hepatology|October 28, 2022
Highly Increased Levels of Inter-α-inhibitor Heavy Chain 4 (ITIH4) in Autoimmune Cholestatic Liver DiseasesTea Lund Laursen, Lars Bossen, Rasmus Pihl, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 10, 2024
Diagnostic and prognostic value of mannan-binding lectin associated protein (MAp19) for functionally relevant coronary artery diseaseGanna Isayeva, Klara Rumora, Eliska Potlukova, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 23, 2024
Trypanosoma brucei Invariant Surface Glycoprotein 75 Is an Immunoglobulin Fc Receptor Inhibiting Complement Activation and Antibody-Mediated Cellular PhagocytosisJakob Hauge Mikkelsen, Kristian Stødkilde, Maria Pauladòttir Jensen, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 6, 2023
Diagnostic and prognostic value of H-ficolin for functionally relevant coronary artery diseaseGanna Isayeva, Eliska Potlukova, Klara Rumora, et al.
Medical Microbiology and Immunology|May 13, 2025
Impact of Staphylococcus aureus colonization and skin abscesses on formation of human anti-αGal antibodiesJens Magnus Bernth Jensen, Khoa Manh Dinh, Lotte Hindhede, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Scandinavian Journal of Immunology|August 29, 2025
Treat-To-Target: Emergence of Second-Generation CD40L Inhibitors for Treatment of SLE-Identifying Beneficial Patient Candidates for CD40L Inhibitors in a Cross-Sectional SLE CohortKathrine Pedersen, Annette Gudmann Hansen, Yaseelan Palarasah, et al.
Journal of Immunological Methods|June 13, 2024
Development of an immunoassay for quantification of soluble human CD40L (CD154) in plasma and serum samplesKathrine Pedersen, Nick Stub Laursen, Annette Gudmann Hansen, et al.
Frontiers in Immunology|August 8, 2022
Structure-Guided Engineering of a Complement Component C3-Binding Nanobody Improves Specificity and Adds Cofactor ActivityHenrik Pedersen, Rasmus Kjeldsen Jensen, Annette Gudmann Hansen, et al.
Clinical and Experimental Immunology|July 5, 2023
Differentiating between activation via the lectin or the classical complement pathway in patients with systemic lupus erythematosusMads Lamm Larsen, Anne Troldborg, Erik J M Toonen, et al.
Frontiers in Immunology|May 21, 2020
Complement Receptor 2 Based Immunoassay Measuring Activation of the Complement System at C3-Level in Plasma Samples From Mice and HumansLene Halkjær, Anne Troldborg, Henrik Pedersen, et al.
Journal of Clinical and Translational Hepatology|October 28, 2022
Highly Increased Levels of Inter-α-inhibitor Heavy Chain 4 (ITIH4) in Autoimmune Cholestatic Liver DiseasesTea Lund Laursen, Lars Bossen, Rasmus Pihl, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 10, 2024
Diagnostic and prognostic value of mannan-binding lectin associated protein (MAp19) for functionally relevant coronary artery diseaseGanna Isayeva, Klara Rumora, Eliska Potlukova, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 23, 2024
Trypanosoma brucei Invariant Surface Glycoprotein 75 Is an Immunoglobulin Fc Receptor Inhibiting Complement Activation and Antibody-Mediated Cellular PhagocytosisJakob Hauge Mikkelsen, Kristian Stødkilde, Maria Pauladòttir Jensen, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 6, 2023
Diagnostic and prognostic value of H-ficolin for functionally relevant coronary artery diseaseGanna Isayeva, Eliska Potlukova, Klara Rumora, et al.
Medical Microbiology and Immunology|May 13, 2025
Impact of Staphylococcus aureus colonization and skin abscesses on formation of human anti-αGal antibodiesJens Magnus Bernth Jensen, Khoa Manh Dinh, Lotte Hindhede, et al.
Pageof 1